Procyon Advisors’s ICU Medical ICUI Stock Holding History

Procyon Advisors’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-38	Closed	-$7K	–	584
2020 Q2	$7K	Hold	38	–	–	﹤0.01%	729
2020 Q1	$8K	Sell	38 -25	-40%	-$4.81K	0.01%	631
2019 Q4	$12K	Buy	+63	New	+$10.8K	0.01%	604

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Procyon Advisors's ICUI Position: Q3 2020 in Review

Procyon Advisors sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 38 shares — an estimated $7K sold.

Procyon Advisors first reported a position in ICUI in Q4 2019 and held it in 3 quarters. The position peaked at $12K in Q4 2019. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

Procyon Advisors reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 38 ICU Medical shares in Q3 2020, an estimated $7K.
Procyon Advisors first reported a position in ICU Medical in Q4 2019 and held it in 3 quarters.
Procyon Advisors's ICU Medical position peaked at $12K in Q4 2019.
283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.